Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PROline and FapI With Late Gadolinium Enhancement in Myocardial Infarction PROFILE-MI - The FAPI Fibrosis Study

NCT05356923 is registered in ClinicalTrials.gov with University of Edinburgh as lead sponsor.

NCT NCT05356923
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05356923 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PROline and FapI With Late Gadolinium Enhancement in Myocardial Infarction PROFILE-MI - The FAPI Fibrosis Study
Lead sponsor
University of Edinburgh
Phase
Observational
Overall status
Completed
Start date
April 21, 2021
Completion date
December 31, 2023
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myocardial fibrosis, myocardial infarction